|
9431 |
The heterogeneity of symptom reporting across study sites: a secondary analysis of a randomised placebo-controlled multicentre antimalarial trial Enthalten in BMC medical research methodology Bd. 23, 4.9.2023, Nr. 1, date:12.2023: 1-10
|
|
|
9432 |
The HortONS study. Treatment of chronic cluster headache with transcutaneous electrical nerve stimulation and occipital nerve stimulation: study protocol for a prospective, investigator-initiated, double-blinded, randomized, placebo-controlled trial Enthalten in BMC neurology Bd. 23, 21.10.2023, Nr. 1, date:12.2023: 1-11
|
|
|
9433 |
The HYSTER study: the effect of intracervically administered terlipressin versus placebo on the number of gaseous emboli and fluid intravasation during hysteroscopic surgery: study protocol for a randomized controlled clinical trial Enthalten in Trials Bd. 19, 14.2.2018, Nr. 1, date:12.2018: 1-6
|
|
|
9434 |
The impact of concurrent granulocyte–macrophage colony-stimulating factor on quality of life in head and neck cancer patients: results of the randomized, placebo-controlled Radiation Therapy Oncology Group 9901 trial Enthalten in Quality of life research Bd. 23, 4.2.2014, Nr. 6, date:8.2014: 1841-1858
|
|
|
9435 |
The impact of fish oil and wheat germ oil combination on mineral-bone and inflammatory markers in maintenance hemodialysis patients: a randomized, double-blind, placebo-controlled clinical trial Enthalten in International urology and nephrology Bd. 49, 30.6.2017, Nr. 10, date:10.2017: 1851-1858
|
|
|
9436 |
The impact of Hafnia alvei HA4597™ on weight loss and glycaemic control after bariatric surgery — study protocol for a triple-blinded, blocked randomized, 12-month, parallel-group, placebo-controlled clinical trial Enthalten in Trials Bd. 24, 29.5.2023, Nr. 1, date:12.2023: 1-13
|
|
|
9437 |
The impact of Lacticaseibacillus paracasei GMNL-143 toothpaste on gingivitis and oral microbiota in adults: a randomized, double-blind, crossover, placebo-controlled trial Enthalten in BMC oral health Bd. 24, 20.4.2024, Nr. 1, date:12.2024: 1-11
|
|
|
9438 |
The impact of migraine prevention on daily activities: a longitudinal and responder analysis from three topiramate placebo-controlled clinical trials Enthalten in Health and quality of life outcomes Bd. 5, 04.10.2007, Nr. 1, date:12.2007: 1-10
|
|
|
9439 |
The impact of missing data on clinical trials: a re-analysis of a placebo controlled trial of Hypericum perforatum (St Johns wort) and sertraline in major depressive disorder Enthalten in Psychopharmacology Bd. 231, 15.11.2013, Nr. 9, date:5.2014: 1987-1999
|
|
|
9440 |
The Impact of OnabotulinumtoxinA vs. Placebo on Efficacy Outcomes in Headache Day Responder and Nonresponder Patients with Chronic Migraine Enthalten in Pain and therapy Bd. 9, 7.10.2020, Nr. 2, date:12.2020: 695-707
|
|